All India Institute of Medical Sciences, New Delhi, India.
Department of Educational Development and Research, Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands and Department of Pediatrics, Dr Horacio E Oduber Hospital, Oranjestad, Aruba.
Leadersh Health Serv (Bradf Engl). 2021 Nov 19;ahead-of-print(ahead-of-print). doi: 10.1108/LHS-05-2021-0045.
PURPOSE: In January 2021, India launched the world's most extensive vaccination campaign against COVID-19. It is estimated that India would need to vaccinate over a billion people to achieve herd immunity. Even though the Indian Government focuses on improving and delivering its vaccination programme, significant challenges still exist. This paper aims to discuss current challenges to scale up India's vaccination campaign and addresses strategies for achieving this. DESIGN/METHODOLOGY/APPROACH: The paper is based on a review of secondary sources, including journal articles from scholarly and grey literature and information available in the public domain. The search focused explicitly on the COVID-19 scenario, vaccination programme, public health management and systems leadership in the Indian health care system. FINDINGS: The analysis revealed that various factors have disrupted India's vaccination campaign, including shortage of vaccine doses, mandatory prior online registration, lack of infrastructure, safety concerns for older people, untrained workforce and absence of a solid public health framework. Furthermore, India appears to have struggled to reduce tensions and instill trust in its ability to effectively manage the COVID-19 pandemic and vaccination programme due to a lack of cooperation between union government, state governments and other stakeholders, namely, policymakers, hospitals, industry and community. ORIGINALITY/VALUE: The findings indicate that scaling up India's anti-COVID vaccination programme would require system-level leadership strategies that work within the country's limited resources. Deeper reforms in vaccine development, storage, delivery, training and regulatory frameworks are also needed to extend the world's largest anti-COVID-19 vaccination campaign.
目的:2021 年 1 月,印度启动了全球规模最大的 COVID-19 疫苗接种运动。据估计,印度需要为超过 10 亿人接种疫苗才能实现群体免疫。尽管印度政府专注于改进和推进其疫苗接种计划,但仍面临重大挑战。本文旨在讨论扩大印度疫苗接种运动所面临的当前挑战,并探讨实现这一目标的策略。
设计/方法/途径:本文基于对二手资料的综述,包括来自学术和灰色文献的期刊文章以及公共领域的信息。搜索重点明确针对 COVID-19 情况、疫苗接种计划、印度医疗保健系统中的公共卫生管理和系统领导。
发现:分析表明,各种因素扰乱了印度的疫苗接种运动,包括疫苗剂量短缺、强制性在线预先注册、基础设施不足、老年人的安全问题、未受过培训的劳动力以及缺乏坚实的公共卫生框架。此外,由于联邦政府、邦政府和其他利益相关者(即政策制定者、医院、行业和社区)之间缺乏合作,印度似乎难以缓解紧张局势并树立对其有效管理 COVID-19 大流行和疫苗接种计划的能力的信任。
原创性/价值:研究结果表明,扩大印度的抗 COVID 疫苗接种计划需要系统层面的领导策略,这些策略要在该国有限的资源范围内发挥作用。还需要对疫苗开发、储存、交付、培训和监管框架进行更深入的改革,以扩大全球最大的抗 COVID-19 疫苗接种运动。
Leadersh Health Serv (Bradf Engl). 2021-11-19
Int J Health Plann Manage. 2022-5
Leadersh Health Serv (Bradf Engl). 2021-12-3
Osong Public Health Res Perspect. 2022-10
Vaccine. 2021-8-31
Diabetes Metab Syndr. 2021
Open Res Eur. 2025-1-10